0001493152-23-013049.txt : 20230420 0001493152-23-013049.hdr.sgml : 20230420 20230420132309 ACCESSION NUMBER: 0001493152-23-013049 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20230414 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Unregistered Sales of Equity Securities ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230420 DATE AS OF CHANGE: 20230420 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MARIZYME INC CENTRAL INDEX KEY: 0001413754 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 825464863 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-53223 FILM NUMBER: 23832349 BUSINESS ADDRESS: STREET 1: 555 HERITAGE DRIVE STREET 2: SUITE 205 CITY: JUPITER STATE: FL ZIP: 33458 BUSINESS PHONE: 561-935-9955 MAIL ADDRESS: STREET 1: 555 HERITAGE DRIVE STREET 2: SUITE 205 CITY: JUPITER STATE: FL ZIP: 33458 FORMER COMPANY: FORMER CONFORMED NAME: GBS Enterprises Inc DATE OF NAME CHANGE: 20100830 FORMER COMPANY: FORMER CONFORMED NAME: Swav Enterprises Ltd. DATE OF NAME CHANGE: 20070928 8-K 1 form8-k.htm
0001413754 false 0001413754 2023-04-14 2023-04-14 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

CURRENT REPORT

 

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): April 14, 2023

 

MARIZYME, INC.
(Exact name of registrant as specified in its charter)

 

Nevada   000-53223   82-5464863

(State or other jurisdiction

of incorporation)

  

(Commission

File Number)

  

(IRS Employer

Identification No.)

 

555 Heritage Drive, Suite 205, Jupiter, Florida   33458
(Address of principal executive offices)   (Zip Code)

 

(561) 935-9955
(Registrant’s telephone number, including area code)

 

 
(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

  ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
  ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
  ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
  ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

 

Emerging Growth Company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Not applicable.        

 

 

 

 

 

 

Item 1.01 Entry into a Material Definitive Agreement.

 

Note Regarding Presentation of Capitalization in this Current Report

 

Unless indicated otherwise, all share amounts, share price amounts and amounts derived from share amounts and share price amounts contained in this Current Report on Form 8-K do not give effect to: (i) the filing of a Certificate of Change Pursuant to Nevada Revised Statutes (“NRS”) 78.209 with the Secretary of State of the State of Nevada (the “Nevada Secretary of State”) on August 3, 2022, which provided for a decrease of the registrant’s authorized common stock from 75,000,000 shares to 18,750,000 shares and corresponding decrease of every four (4) shares of the registrant’s issued and outstanding shares of common stock into one (1) share, and which became effective upon filing; (ii) the filing of a Certificate of Change Pursuant to NRS 78.209 with the Nevada Secretary of State on January 5, 2023, which provided for a decrease of the registrant’s authorized common stock from 75,000,000 shares to 20,000,000 shares and a corresponding change of every three-and-three-quarters (3.75) shares of the registrant’s issued and outstanding shares of common stock to one (1) share, and which became effective upon filing; (iii) the filing of a Certificate of Change Pursuant to NRS 78.209 with the Nevada Secretary of State on January 13, 2023, which provided for the increase of the registrant’s authorized common stock from 20,000,000 shares to 75,000,000 shares and the corresponding increase of every issued and outstanding share of the registrant’s common stock to three-and-three-quarters (3.75) shares, and which became effective at 4:45 PM Pacific Time on January 17, 2023; (iv) the filing of a Certificate of Change Pursuant to NRS 78.209 with the Nevada Secretary of State on January 13, 2023, which provided for the increase of the registrant’s authorized common stock from 75,000,000 shares to 300,000,000 shares and the corresponding increase of every issued and outstanding share of the registrant’s common stock to three-and-three-quarters (3.75) shares, and which became effective at 5:00 PM Pacific Time on January 17, 2023; and (v) the filing of a Certificate of Change Pursuant to NRS 78.209 with the Nevada Secretary of State on January 13, 2023, which provided for the decrease of the registrant’s authorized common stock from 300,000,000 to 20,000,000 and the corresponding change of every fifteen (15) shares of the registrant’s issued and outstanding common stock to one (1) share, and became effective at 5:15 PM Pacific Time on January 17, 2023. See “Part I. Note Regarding Presentation of Capitalization in this Current Report” of the registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022, filed on March 24, 2023, for related discussion, which is incorporated by reference herein.

 

Exercise of Somahlution Warrants with Reduced Exercise Price

 

As previously reported in Current Reports on Form 8-K filed by Marizyme, Inc. (the “Company”) on December 19, 2019 and August 5, 2020, on December 15, 2019, the Company entered into an asset purchase agreement, as amended on March 31, 2020, May 29, 2020, and July 30, 2020 (the “Asset Purchase Agreement”), with Somahlution, LLC, a Delaware limited liability company (“Somahlution, LLC”), Somahlution, Inc., a Delaware corporation (“Somahlution, Inc.”), and Somaceutica, LLC, a Delaware limited liability company (collectively, the “Sellers”). Pursuant to the terms of the Asset Purchase Agreement, the Company agreed to purchase all of the assets and none of the liabilities of the Sellers, provided that the Company agreed to acquire the outstanding capital stock of Somahlution, Inc., held by Somahlution, LLC, rather than the assets of Somahlution, Inc. (the “Acquisition”). On August 4, 2020, the Acquisition closed. As consideration for the Acquisition, the Company issued to certain designees of the Sellers (the “Warrant Holders”) a total of 10,000,000 restricted shares of common stock and five-year warrants to purchase an additional 2,999,955 shares of common stock with an exercise price of $5.00 per share (the “Somahlution Warrants”).

 

On April 13, 2023, Marizyme, Inc. (the “Company”) delivered offer letter agreements (the “Somahlution Warrant Offer Letter Agreements”) to the Warrant Holders, which offered to allow the Warrant Holders to exercise the Somahlution Warrants to purchase the number of restricted shares of common stock issuable under their Somahlution Warrants at an exercise price reduced by the Company from $5.00 per share to $0.10 per share, on or prior to April 21, 2023, for maximum total cash proceeds of $299,995.50. Since April 14, 2023, and as of the date of this Current Report on Form 8-K, four of the Warrant Holders had entered into Somahlution Warrant Offer Letter Agreements and had exercised their Somahlution Warrants to purchase a total of 2,652,159 shares of common stock for gross proceeds of approximately $265,216 the (the “Warrant Exercise”). Univest Securities, LLC, as the Company’s placement agent (“Univest”), which facilitated the Warrant Exercise, waived any fees or reimbursable expenses that would otherwise have been payable with respect to the Warrant Exercise pursuant to the Placement Agency Agreement, dated as of December 21, 2021, between Univest and the Company.

 

The foregoing description of the Somahlution Warrant Offer Letter Agreements is qualified in its entirety by reference to the form of such documents which is filed as Exhibit 10.1 to this Current Report on Form 8-K.

 

2

 

 

Adjustment to Conversion Price of Convertible Notes and Exercise Price of Class C Warrants

 

As previously reported in a Current Report on Form 8-K filed by the Company on January 17, 2023 (the “January 2023 Form 8-K”), which is incorporated by reference herein, from May 2021 to August 2022, the Company conducted a private placement (the “Units Private Placement”) of units consisting of 10% secured convertible promissory notes (the “Convertible Notes”) and accompanying warrants (the “Class C Warrants”), as were modified or amended from time to time, with Univest, the terms of which were described in detail in the January 2023 Form 8-K. As reported in the January 2023 Form 8-K, among their other terms, the Convertible Notes and Class C Warrants provide that a lower price per share, or more favorable terms, respectively, under subsequent equity issuances, not including qualified financings and certain other exempt issuances, will be applicable to the conversion or exercise rights under the Convertible Notes and Class C Warrants, respectively. In addition, as reported in the January 2023 Form 8-K, under a Letter Agreement between the Company and Univest as placement agent for the investors in the Units Private Placement, dated January 12, 2023 (the “Univest Letter Agreement”), the parties agreed that simultaneously with any adjustment to the exercise price under the Class C Warrants as a result of any equity issuances, not including qualified financings and certain other exempt issuances, the number of shares of common stock that may be purchased under the Class C Warrants will be increased such that the aggregate exercise price of such shares will be the same as the same as the aggregate exercise price in effect immediately prior to the adjustment, without regard to any limitations on exercise contained in the Class C Warrants, including the beneficial ownership limitation described above.

 

At the time of the Warrant Exercise, the Convertible Notes were convertible at a conversion price of $1.75 per share and the Class C Warrants were exercisable at an exercise price of $2.25 per share. Outstanding Convertible Notes have underlying principal of $14,471,177, and outstanding Class C Warrants were exercisable to purchase a total of 16,538,473 shares of common stock. In connection with the transaction contemplated by the Somahlution Warrant Offer Letter Agreements and certain unrelated matters, the Company obtained exercise and conversion rights waivers and amendments from certain holders of the Convertible Notes and Class C Warrants, which reduced the principal underlying Convertible Notes’ with conversion rights to Convertible Notes with a total of $4,471,177 in principal, and reduced outstanding Class C Warrants with exercise rights to Class C Warrants having exercise rights to Class C Warrants exercisable to purchase 5,109,904 shares of common stock. As a result of the Warrant Exercise and pursuant to the adjustment provisions described above, the conversion price of the Convertible Notes and the exercise price of the Class C Warrants adjusted to $0.10 per share. As a result of these adjustment provisions and the conversion and exercise terms of the Convertible Notes and Class C Warrants, the number of shares into which the Convertible Notes may be converted adjusted from 2,554,944 shares of common stock, not including shares convertible from interest under the Convertible Notes, to 44,711,770 shares of common stock, not including shares convertible from interest under the Convertible Notes, subject to rounding adjustments, and the number of shares that the Class C Warrants may be exercised to purchase adjusted from 5,109,904 shares of common stock to 114,972,840 shares, subject to rounding adjustments.

 

The foregoing description of the Univest Letter Agreement, the Convertible Notes and the Class C Warrants is qualified in its entirety by reference to the description of these and related documents and transactions in “Item 1.01 Entry into a Material Definitive Agreement.” of the January 2023 Form 8-K.

 

Item 3.02. Unregistered Sales of Equity Securities.

 

The disclosure set forth under “Item 1.01. Entry into a Material Definitive Agreement – Note Regarding Presentation of Capitalization in this Current Report” and “Item 1.01. Entry into a Material Definitive Agreement – Exercise of Somahlution Warrants with Reduced Exercise Price” is incorporated by reference into this Item 3.02. The offer of securities pursuant to the Somahlution Warrant Offer Letter Agreements and sale of restricted common stock pursuant to the exercise of the Somahlution Warrants described above was conducted as a private placement pursuant to and in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and Rule 506(b) of Regulation D promulgated thereunder (“Regulation D”) for transactions not involving a public offering. In connection with the execution of the Somahlution Warrant Offer Letter Agreements, each of the Warrant Holders represented that such Warrant Holder was an “accredited investor” as such term is defined in Rule 501(a) of Regulation D.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.   Description of Exhibit
     
10.1   Form of Letter Agreement with certain holders of Common Share Purchase Warrants of Marizyme, Inc. dated August 4, 2020
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

3

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, Marizyme, Inc. has duly caused this current report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: April 20, 2023 MARIZYME, INC
     
  By: /s/ David Barthel
    David Barthel
    Chief Executive Officer

 

4

 EX-10.1 2 ex10-1.htm

 

Exhibit 10.1

 

MARIZYME, INC.

555 Heritage Drive, Suite 205

Jupiter, Florida 33458

 

April 13, 2023

 

Dear Warrant Holder:

 

Reference is made to the Common Share Purchase Warrants of Marizyme, Inc. (the “Company”) dated August 4, 2020 (the “Warrants”). According to the Company’s records, you are a holder of one or more of the Warrants (“you” or the “Warrant Holder”). All capitalized terms used but not otherwise defined herein shall have the respective meanings given to them in the Warrants.

 

The Company is writing to offer a temporary reduction in the Exercise Price under the Warrant from $5.00 to $0.10,1 subject to the terms of this letter (the “Reduced Exercise Price”).

 

To accept this offer, you must do all of the following by no later than April 21, 2023: (1) Countersign this letter indicating your agreement to an amendment to any Warrants held by you to provide for the Reduced Exercise Price pursuant to Section 15(a) of the Warrants; (2) complete and deliver the questionnaire attached hereto as Attachment 1 that certifies that you are an “accredited investor” within the meaning of Rule 501(a) of Regulation D as promulgated under the Securities Act of 1933, as amended; (3) Fully exercise any Warrants held by you by completion and delivery to the Company of an Exercise Notice in the form attached hereto as Attachment 2; and (4) pay the full exercise price of the exercised Warrants to the Company in cash to the bank account specified in the information attached hereto as Attachment 3, in accordance with the terms of the Warrants. Upon receipt of payment for exercise, duly-executed exercise notice and questionnaire, the Company will issue the number of shares of common stock provided for under exercised Warrants. As provided in the Warrants, the shares will have restrictions on transfer. If you choose not to participate in this offer according to its terms on or prior to April 21, 2023, with the Company receiving cash on or prior to such date, then the original terms of the Warrant will remain unchanged. Specifically, the Exercise Price under the Warrant will remain at $5.00.

 

This letter shall constitute a notice to each Warrant Holder with respect to the foregoing pursuant to Section 12 of the Warrants.

 

  Very truly yours,
   
  Marizyme, Inc.
     
  By: /s/ David Barthel
  Name: David Barthel
  Title: Chief Executive Officer

 

ACCEPTED AND AGREED:

 

WARRANT HOLDER

 

If an individual:

 

__________________________

 

Name:

 

If an entity:

 

Name of Warrant Holder:  
              
By:    
Name:    
Title:    

 

 

1 All share and share price amounts referenced herein do not give effect to any stock splits, stock combinations, recapitalizations or similar transactions of the common stock of the Company that have not been reflected in the market price of the common stock of the Company quoted on the OTCQB tier of OTC Markets Group, Inc. as of the date hereof. All shares of common stock that are issuable pursuant to exercise of the Warrants shall be subject to an equitable adjustment for any such stock splits, stock combinations, recapitalizations or similar transactions.

 

 

 

 

Attachment 1

 

Questionnaire

 

(Separately attached)

 

 

 

 

Attachment 2

 

Exercise Notice

 

Ladies and Gentlemen:

 

(1) The undersigned hereby elects to exercise the above-referenced Warrant with respect to ______________ Common Shares. Capitalized terms used herein and not otherwise defined herein have the respective meanings set forth in the Warrant.

 

(2) The Holder intends that payment of the Exercise Price shall be made as (check one):

 

☐ Cash Exercise under Section 4(b)

 

☐ Cashless Exercise under Section 4(c) (assuming conditions precedent are met)

 

(3) If the Holder has elected a Cash Exercise, the holder shall pay the sum of $ ______________ to the Company in accordance with the terms of the Warrant.

 

(4) Pursuant to this Exercise Notice, the Company shall deliver to the Holder ________________ Warrant Shares determined in accordance with the terms of the Warrant.

 

Dated:   HOLDER:
         
       
      Print name
         
      By:                   
         
      Title:  

 

 

 

 

Attachment 3

 

Exercise Payment Instructions

 

(Separately attached)

 

 

 

 EX-101.SCH 3 mrzm-20230414.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 mrzm-20230414_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 mrzm-20230414_pre.xml XBRL PRESENTATION FILE XML 6 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover
Apr. 14, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Apr. 14, 2023
Entity File Number 000-53223
Entity Registrant Name MARIZYME, INC.
Entity Central Index Key 0001413754
Entity Tax Identification Number 82-5464863
Entity Incorporation, State or Country Code NV
Entity Address, Address Line One 555 Heritage Drive
Entity Address, Address Line Two Suite 205
Entity Address, City or Town Jupiter
Entity Address, State or Province FL
Entity Address, Postal Zip Code 33458
City Area Code (561)
Local Phone Number 935-9955
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Not applicable.
Entity Emerging Growth Company false
XML 7 form8-k_htm.xml IDEA: XBRL DOCUMENT 0001413754 2023-04-14 2023-04-14 iso4217:USD shares iso4217:USD shares 0001413754 false 8-K 2023-04-14 MARIZYME, INC. NV 000-53223 82-5464863 555 Heritage Drive Suite 205 Jupiter FL 33458 (561) 935-9955 false false false false false Not applicable. EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 1 21 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://marizyme.com/role/Cover Cover Cover 1 false false All Reports Book All Reports form8-k.htm ex10-1.htm mrzm-20230414.xsd mrzm-20230414_lab.xml mrzm-20230414_pre.xml http://xbrl.sec.gov/dei/2022 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form8-k.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 21 }, "contextCount": 1, "dts": { "inline": { "local": [ "form8-k.htm" ] }, "labelLink": { "local": [ "mrzm-20230414_lab.xml" ] }, "presentationLink": { "local": [ "mrzm-20230414_pre.xml" ] }, "schema": { "local": [ "mrzm-20230414.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 59, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 21, "memberCustom": 0, "memberStandard": 0, "nsprefix": "MRZM", "nsuri": "http://marizyme.com/20230414", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form8-k.htm", "contextRef": "From2023-04-14to2023-04-14", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://marizyme.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form8-k.htm", "contextRef": "From2023-04-14to2023-04-14", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://marizyme.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r10": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r11": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r12": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r13": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r14": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r15": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r18": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r19": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r9": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 14 0001493152-23-013049-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-23-013049-xbrl.zip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end